Taiwan News19h
Global Pharmaceutical Manufacturing Market to Soar from US$ 859.5 Billion in 2023 to US$ 2,301.6 Billion by 2032, Growing at a CAGR of 11.56%
With a market projected to reach US$ 2,301.6 billion by 2032, the pharmaceutical manufacturing industry is not just growing—it’s evolving. The convergence of digital innovation, changing disease ...
Aspargo Labs Expands Global Leadership Team
Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting ...
Real Chemistry Strengthens Presence in Europe with Key Leadership Moves
Camilla Griffiths named President of 21GRAMS Europe; Mike Nelson relocated to London in new International Client Development ...
Former Pfizer R&D Chief Mikael Dolsten Joins Formation Bio to Chair Drug Picking Committee and Co-Chair its Investment Advisory Committee
Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...
Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal
Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...
JD Supra6d
Seller Considerations When Negotiating a Letter of Intent
Negotiating and signing a Letter of Intent (LOI) is a key inflection point in the process of selling ... complying with an integration plan or product development milestones tied to the buyer ...
Financial Post6d
Real Chemistry Strengthens Presence in Europe with Key Leadership Moves
In parallel, Mike Nelson, President, Integrated Communications, has relocated from the U.S. to London to drive international client development ... has been a key strategic leader, partnering with ...
Zenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 Catalyst
Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...
Artisan Global Opportunities Fund Trimmed its Position in Novo Nordisk A/S (NVO)
Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...
pharmaphorum3d
Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms
The first part of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year ...